Science Explorer Interactive view Map
Company · Scandicci · Italy

Molteni Farmaceutici (Italy)

moltenifarma.it/?lang=enROR OpenAlex
Research works
40
▼ 57% vs 2013–17
Citations
1.4k
33.4 per fractional work
Top-10% rate
24.4%
record average 16.5%
Open access
20%
world 28%

Not ranked overall: Molteni Farmaceutici (Italy) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.68× its world share, 0 worksBiochemistry, Geneti…Chemistry: 3.46× its world share, 0 worksChemistryComputer Science: 1.40× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 3.47× its world share, 0 worksEarth and Planetary …Engineering: 2.42× its world share, 1 worksEngineeringEnvironmental Science: 2.19× its world share, 0 worksEnvironmental ScienceMaterials Science: 1.04× its world share, 0 worksMaterials ScienceMedicine: 1.24× its world share, 1 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Earth and Planetary Sciences, 3.5×. Every wedge is a field page.

Which keywords describe research at Molteni Farmaceutici (Italy)?

By fractional works in all years, weighted toward what it does more of than the world: Nanoparticles, Photodynamic Therapy, Reactive Oxygen Species, Antimicrobial, Cancer Treatment, Photosensitizers, Singlet Oxygen and Synthesis.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 38 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 38 words, with their numbers
  1. Nanoparticles9▲ 17×4 topics
  2. Photodynamic Therapy8▲ 133×2 topics
  3. Reactive Oxygen Species8▲ 42×2 topics
  4. Antimicrobial5▲ 51×4 topics
  5. Cancer Treatment5▲ 46×2 topics
  6. Photosensitizers5▲ 478×1 topic
  7. Singlet Oxygen5▲ 478×1 topic
  8. Synthesis4▲ 17×10 topics
  9. Fluorescence Imaging4▲ 86×1 topic
  10. Photothermal Therapy4▲ 115×1 topic
  11. Phthalocyanines3▲ 158×1 topic
  12. Porphyrins3▲ 158×1 topic
  13. Drug Discovery2▲ 15×5 topics
  14. Heterocycles2▲ 28×4 topics
  15. Biological Evaluation2▲ 39×4 topics
  16. Catalyst2▲ 45×2 topics
  17. Inflammation2▲ 1.75×11 topics
  18. Medicinal Chemistry2▲ 11×5 topics
  19. Anticancer Agents2▲ 15×4 topics
  20. Depression1▲ 4.4×3 topics
  21. Imidazoles1▲ 116×1 topic
  22. Method Validation1▲ 43×2 topics
  23. Oxazolones1▲ 116×1 topic
  24. Anxiety1▲ 8.3×2 topics
  25. Green Analytical Chemistry1▲ 31×1 topic
  26. Liquid Chromatography1▲ 19×2 topics
  27. Neuropeptides1▲ 28×2 topics
  28. Pharmaceutical Analysis1▲ 94×1 topic
  29. Cell Signaling1▲ 7.8×2 topics
  30. Epidemiology1▼ 0.68×9 topics
  31. Opioid1▲ 43×1 topic
  32. Receptors1▲ 43×1 topic
  33. Wound Healing1▲ 12×6 topics
  34. Antimicrobial Activity1▲ 13×2 topics
  35. Biosensors1▲ 4.3×3 topics
  36. Chiral Separation1▲ 20×1 topic
  37. Gas Chromatography1▲ 20×1 topic
  38. Metabolic Syndrome1▲ 2.9×5 topics

Which research topics does Molteni Farmaceutici (Italy) publish most on?

By volume in 2022–2025: Antenna Design and Optimization, Radar Systems and Signal Processing, Direction-of-Arrival Estimation Techniques and Microbial Fuel Cells and Bioremediation.

Antenna Design and Optimization: 0 fractional worksRadar Systems and Signal Processing: 0 fractional worksDirection-of-Arrival Est…0Direction-of-Arrival Estimation Techniques: 0 fractional worksMicrobial Fuel Cells and…0Microbial Fuel Cells and Bioremediation: 0 fractional worksElectrochemical sensors …0Electrochemical sensors and biosensors: 0 fractional worksFuel Cells and Related M…0Fuel Cells and Related Materials: 0 fractional worksGenetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities: 0 fractional worksReproductive Biology and Fertility: 0 fractional worksNanoplatforms for cancer theranostics: 0 fractional worksSperm and Testicular Function: 0 fractional works
Aerospace EngineeringSignal ProcessingEnvironmental EngineeringElectrical and Electronic Engineering4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Antenna Design and Optimization Aerospace Engineering 0 works
  2. 2 Radar Systems and Signal Processing Aerospace Engineering 0 works
  3. 3 Direction-of-Arrival Estimation Techniques Signal Processing 0 works
  4. 4 Microbial Fuel Cells and Bioremediation Environmental Engineering 0 works
  5. 5 Electrochemical sensors and biosensors Electrical and Electronic Engineering 0 works
  6. 6 Fuel Cells and Related Materials Electrical and Electronic Engineering 0 works
  7. 7 Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities Genetics 0 works
  8. 8 Reproductive Biology and Fertility Public Health, Environmental and Occupational Health 0 works
  9. 9 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
  10. 10 Sperm and Testicular Function Reproductive Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available20.0%not open80.0%

World: 28% of research is openly available.

with international co-authors13.2%domestic only86.8%

World: 19% is written across borders.

How has Molteni Farmaceutici (Italy)'s research output changed?

Output in 2018–2022 was 57% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.